Taylor Barger
Physician Assistant · Montoursville, PANPI 1053740696
Payments from drug & device makers
Across 410 payments — averaging $17.99 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$3K
- AbbVie$2K
- Amgen$640
- Lilly USA, LLC$625
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$274
- Abbott$239
- plus $907 from 19 others
What the payments were for
- Consulting fees$1,59022%
- Food & beverage$5,78678%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 107 | $2,914 |
| AbbVie | 151 | $1,776 |
| Amgen | 33 | $640 |
| Lilly USA, LLC | 35 | $625 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 19 | $274 |
| Abbott | 9 | $239 |
| Pfizer | 14 | $227 |
| Amarin Pharma, Inc. | 6 | $101 |
| GSK | 7 | $99 |
| Ardelyx, Inc. | 5 | $97 |
| Phathom Pharmaceuticals, Inc. | 4 | $79 |
| Novartis | 3 | $42 |
| Sanofi-aventis U.S. LLC | 3 | $36 |
| AstraZeneca | 2 | $30 |
| Boehringer Ingelheim | 2 | $26 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $25 |
| Merck | 1 | $22 |
| Boston Scientific | 1 | $21 |
| Grifols USA, LLC | 1 | $18 |
| Johnson & Johnson | 1 | $16 |
| Genentech USA, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Cequr Corporation | 1 | $14 |
| Astellas Pharma US Inc | 1 | $13 |
| Biohaven Pharmaceuticals, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,376 in reported general payments places this provider in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 140 | $121,061 |
| OzempicSemaglutide | 98 | $112,891 |
| Humira PenAdalimumab | 13 | $95,362 |
| XifaxanRifaximin | 26 | $88,219 |
| JardianceEmpagliflozin | 77 | $84,660 |
| MounjaroTirzepatide | 69 | $71,106 |
| XareltoRivaroxaban | 44 | $34,563 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 34 | $33,015 |
| MyrbetriqMirabegron | 50 | $25,206 |
| Repatha SureclickEvolocumab | 30 | $21,933 |
| TrulicityDulaglutide | 21 | $21,701 |
| EntrestoSacubitril/Valsartan | 25 | $20,905 |
| FarxigaDapagliflozin Propanediol | 17 | $20,690 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 29 | $16,204 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 11 | $6,194 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $227 | $121,061140 claims |
| Novo NordiskOzempic | $2,914 | $112,89198 claims |
| Lilly USA, LLCMounjaro, Trulicity | $625 | $92,80790 claims |
| Boehringer IngelheimJardiance, Combivent Respimat | $26 | $90,85488 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan | $274 | $88,21926 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $99 | $49,21863 claims |
| Johnson & JohnsonXarelto | $16 | $34,56344 claims |
| Astellas Pharma US IncMyrbetriq | $13 | $25,20650 claims |
| AstraZenecaFarxiga, Nexium | $30 | $23,88729 claims |
| NovartisEntresto | $42 | $20,90525 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in Montoursville
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
- Jeffrey CameronWashington$89K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.